Alexander R. Vartanov

Hematology Oncology | Transplant Surgery

3401 N. Broad Street
Philadelphia, PA 19140

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Journal: Research square

Published: November 19, 2025

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Journal: Blood cancer journal

Published: September 13, 2025

Prephase steroid use and association with dose delays and outcomes in a real-world cohort of older adults treated for diffuse large B-cell lymphoma.

Prephase steroid use and association with dose delays and outcomes in a real-world cohort of older adults treated for diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: January 08, 2025

Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19.

Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19.

Journal: Cureus

Published: February 26, 2022

High-grade heart block associated with ibrutinib therapy.

High-grade heart block associated with ibrutinib therapy.

Journal: HeartRhythm case reports

Published: July 01, 2021

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia.

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia.

Journal: Leukemia

Published: April 14, 2021

An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia.

An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia.

Journal: Journal of investigative medicine high impact case reports

Published: February 03, 2021

Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review.

Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review.

Journal: Respiratory medicine case reports

Published: November 06, 2020

Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia.

Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: October 17, 2018

Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort.

Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort.

Journal: British journal of haematology

Published: January 05, 2015

Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.

Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.

Journal: Blood

Published: April 30, 2014

Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.

Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.

Journal: JAMA dermatology

Published: January 17, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026